Growing clinical acceptance of aggressive cytoreduction strategies. »
10/20/25

Total lesion glycolysis of all bone lesions from PET/CT independent prognostic factor. »
10/21/25

Combination of chemotherapy with ICIs in NSCLC patients with AGAs demonstrated similar clinical outcomes. »
10/21/25

Higher body mass index associated with increased odds of overall EC. »
10/21/25

FL496 appears to be strikingly more effective in inhibiting MPM tumor growth. »
10/21/25

IORT combined with SRT for additional BM demonstrated superior dosimetric properties. »
10/21/25

Tumor-associated myeloid cell persistence as driver of disease progression and poor survival in colorectal cancer. »
10/21/25

PCR analysis indicated decrease in Bcl2 gene expression and increase of Bax gene expression. »
10/22/25

ESC-RCC should be considered when encountering well-defined cystic-solid lesion without calcification. »
10/16/25

Non-pCR cases showed higher proportions of immunosuppressive CD4 + FOXP3 + IC. »
10/21/25